In March 2023, Novo Nordisk was suspended from the ABPI for a period of two years, for engaging in misleading marketing practices that amounted to "bribing health professionals with inducement to prescribe".[59] This is only the eighth time in the last 40 years that ABPI sanctioned a member organization.

https://en.m.wikipedia.org/wiki/Novo_Nordisk